NG-52

CAS No. 212779-48-1

NG-52 ( Compound 52 )

Catalog No. M13385 CAS No. 212779-48-1

NG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 88 In Stock
5MG 144 In Stock
10MG 255 In Stock
25MG 489 In Stock
50MG 705 In Stock
100MG 981 In Stock
500MG 1971 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NG-52
  • Note
    Research use only, not for human use.
  • Brief Description
    NG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase.
  • Description
    NG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase, Cdc28p (IC50 = 7 μM).
  • Synonyms
    Compound 52
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    Cdc28p
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    212779-48-1
  • Formula Weight
    346.81
  • Molecular Formula
    C16H19ClN6O
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: > 100mM
  • SMILES
    CC(C)N1C2=NC(NCCO)=NC(NC3=CC=CC(Cl)=C3)=C2N=C1
  • Chemical Name
    2-((6-((3-chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)ethan-1-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.ray NS, et al. Science. 1998 Jul 24;281(5376):533-8.
molnova catalog
related products
  • Riviciclib

    A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.

  • Indirubin-3-monoxime

    Indirubin-3-monoxime is an effective inhibitor of cyclin-dependent protein kinases, and may play an obligate role in neuronal apoptosis in Alzheimer's disease.

  • iCDK9

    iCDK9 (i-CDK9) is a potent, highly selective CDK9 inhibitor (IC50<0.4 nM, CDK9-CycT1 kinase), exhibits >600-fold selectivity toward CDK1-CycB, CDK2-CycA, CDK4-CycD1, CDK7-CycH-MAT1 and CDK8-CycC.